TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biorecro AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,169
|
3,034
|
2,102 |
| Financial expenses |
244
|
626
|
3 |
| Earnings before taxes |
83
|
-1,062
|
-55 |
| EBITDA |
298
|
-436
|
-52 |
| Total assets |
3,817
|
2,532
|
1,749 |
| Current assets |
367
|
2,532
|
1,749 |
| Current liabilities |
2,367
|
1,699
|
985 |
| Equity capital |
116
|
33
|
764 |
| - share capital |
51
|
51
|
51 |
| Employees (average) |
4
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
3.0%
|
1.3%
|
43.7% |
| Turnover per employee |
792
|
1,011
|
701 |
| Profit as a percentage of turnover |
2.6%
|
-35.0%
|
-2.6% |
| Return on assets (ROA) |
8.6%
|
-17.2%
|
-3.0% |
| Current ratio |
15.5%
|
149.0%
|
177.6% |
| Return on equity (ROE) |
71.6%
|
-3218.2%
|
-7.2% |
| Change turnover |
135
|
932
|
141 |
| Change turnover % |
4%
|
44%
|
7% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.